Walking pneumonia is not dangerous for most people. It’s the mildest form of pneumonia, and the majority of those who get it recover at home without hospitalization. But the nickname is misleading. The fact that you can “walk around” with it doesn’t mean it’s harmless, especially for certain groups. In uncommon cases, walking pneumonia can trigger serious complications affecting the brain, blood, kidneys, and skin.
What Walking Pneumonia Actually Is
Walking pneumonia is a lung infection caused by a bacterium called Mycoplasma pneumoniae. About 2 million of these infections occur in the United States each year. Unlike typical bacterial pneumonia, which can put you flat on your back with high fever and severe breathing difficulty, walking pneumonia tends to produce milder symptoms: a persistent dry cough, low-grade fever, fatigue, and a general feeling of being run down. Most people keep going to work or school, which is how the infection got its casual name.
The infection spreads through respiratory droplets when someone coughs or sneezes. It’s most common in school-age children and young adults, though anyone can get it. After the COVID-19 pandemic suppressed its spread for several years, Mycoplasma pneumoniae began re-emerging globally in 2023. By 2024, the CDC identified an increase in infections, including in young children, a shift from the usual pattern of older children and teens being most affected.
When It Becomes Dangerous
For an otherwise healthy person, walking pneumonia is more of a nuisance than a threat. The danger comes when the infection moves beyond the lungs or hits someone whose body can’t handle the added stress. The CDC lists several serious complications that, while uncommon, can require hospitalization:
- Brain inflammation (encephalitis): This is the most common neurological complication, occurring in roughly 1 out of every 1,000 Mycoplasma infections. Other nervous system problems include meningitis, loss of coordination, and in rare cases, stroke or coma.
- Hemolytic anemia: The infection can trigger the immune system to destroy its own red blood cells, reducing oxygen delivery throughout the body.
- Kidney problems: Renal dysfunction can develop as the immune response to the infection affects organs beyond the lungs.
- Severe skin reactions: Stevens-Johnson syndrome and a related condition called mycoplasma-induced rash and mucositis cause painful blistering of the skin and mucous membranes. During one outbreak in Colorado, eight patients developed these skin reactions in connection with confirmed or probable Mycoplasma infection.
- Severe pneumonia: What starts as a mild lung infection can occasionally progress to serious pneumonia or acute respiratory distress syndrome.
Fatal complications are rare but documented. They include blood clotting disorders, a condition where the immune system attacks the body’s own tissues, and widespread inflammation. These outcomes are the exception, not the rule, but they’re worth knowing about, particularly if symptoms worsen instead of improving.
Who Faces the Highest Risk
Walking pneumonia hits harder in people with existing lung conditions. People hospitalized for asthma flare-ups are six times more likely to have an active Mycoplasma infection than those without one. Research has shown that Mycoplasma pneumoniae is the only atypical respiratory infection directly associated with hospitalization for asthma or COPD exacerbations. Even in people with mild COPD, the number of flare-ups increases during a Mycoplasma infection regardless of how severe their baseline lung disease is.
Beyond lung conditions, people with weakened immune systems and those with blood disorders like sickle cell disease face higher risks. Young children and older adults also tend to have a harder time clearing the infection. If you fall into any of these categories and develop a lingering cough with fatigue, it’s worth getting evaluated sooner rather than later.
Why It Often Goes Undiagnosed
One of the sneakier aspects of walking pneumonia is how hard it is to confirm. There’s no single test that reliably and rapidly identifies Mycoplasma pneumoniae. The Infectious Diseases Society of America has acknowledged this gap directly, noting that treatment usually has to be started based on symptoms alone rather than waiting for lab confirmation.
Blood tests for antibodies depend heavily on timing. If drawn too early, the body hasn’t produced enough antibodies to detect. If only one sample is taken instead of a pair spaced two to three weeks apart, results can be misleading. Adults in particular may not produce the specific antibody response that makes these tests useful. Molecular testing (PCR) is more specific, with about 96% accuracy when it gives a positive result, but it only catches about 62% of true infections. Its accuracy also drops if the sample is collected more than a week after symptoms start.
This diagnostic difficulty means many cases of walking pneumonia are never formally identified. People assume they have a bad cold or bronchitis, and in most cases, that lack of diagnosis doesn’t matter because they recover anyway. But it can matter for vulnerable individuals who might benefit from targeted treatment.
Treatment and Antibiotic Resistance
Most walking pneumonia cases resolve on their own with rest, fluids, and over-the-counter medications for fever and cough. When antibiotics are prescribed, doctors typically use a class called macrolides. These work well in most of the United States, where resistance rates remain below 10%. But resistance varies dramatically by region. In parts of the U.S. South and East, resistance has exceeded 20% during outbreaks. Globally, the picture is more concerning: overall macrolide resistance sits around 28%, and one study from southern China found a staggering 96.4% resistance rate after COVID-19.
If a standard antibiotic isn’t working and your cough and fever persist or worsen after several days of treatment, resistance could be the reason. Alternative antibiotics exist, but this is a situation where your doctor would need to reassess the approach.
What Recovery Looks Like
Some people bounce back in one to two weeks and return to their normal routines. For others, full recovery takes a month or longer. Fatigue is the symptom that lingers most stubbornly. Most people continue feeling tired for about a month even after the cough and fever have cleared. The cough itself can persist for weeks, which is normal and doesn’t necessarily mean the infection is still active.
Pushing yourself to return to full activity too quickly can extend recovery. If you’re still winded doing things that were easy before, your body is telling you it needs more time. This is especially true for people with asthma or other lung conditions, where a walking pneumonia infection can leave airways more reactive and sensitive for weeks after the bacteria are gone.